Corey McCann

Corey M.
McCann is the founder of Alcyone Therapeutics, Inc. (founded in 2010) and Pear Therapeutics (US), Inc. (founded in 2013), where he holds the title of President & Director.
Dr. McCann is also the founder of Companion PBx, Inc. Dr. McCann's current job(s) include being the Co-Chairman at Turing Medical technologies, Inc. since 2020, a Director at Dragonfly Sciences, Inc., a Director at Pear Therapeutics, Inc. since 2021, a Director at Eternia Group LLC since 2011, a Director at Eternia Group SRL since 2021, and a Managing Partner at T.Rx Cap LLC since 2023.
Dr. McCann's former job(s) include being a Director at SentryHealth, Inc. (Kentucky) from 2013 to 2019, a Director at Resolute Bio, Inc. from 2016 to 2019, a Founding Member at Arthromeda, Inc., a Principal at MPM BioImpact, Inc., a Principal at McKinsey & Co., Inc. in 2011, an Associate at RiverVest Venture Management LLC, and an Analyst at Neuroinsights LLC.
Dr. McCann's education history includes a doctorate degree from Harvard University, an undergraduate degree from The Pennsylvania State University, and a doctorate degree from Washington University School of Medicine.